Last updated: Oct 13, 2026, 12:49 PM UTC
Latest Officer Sales $25K+
Browse recent insider trading sales of $25,000 or more by company officers, including CEOs, CFOs, and vice presidents. In the most recent SEC Form 4 filing, OneMedNet Corp's chief financial officer reported selling 8,500 ONMD shares at $6.50 each. The table shows each officer's role, sale value, and change in holdings. Use the color tags and SEC links to check for stock-plan or prearranged-trade details.
These filings are deferred by 6 hours & limited to 50 category trades. Sign up for real time updates and 20 years of data.
View Latest Alerts
Notable Patterns
Latest Cluster Buys
Latest Penny Stock Buys
Biggest Buys This Week
Biggest Buys This Month
Latest Insider Trading - All Filings
Latest Insider Purchases
Latest Insider Purchases $25K+
Latest Insider Purchases $100K+
Latest Officer Purchases $25K+
Latest Officer Purchases $100K+
Latest CEO/CFO Purchases $25K+
Latest CEO/CFO Purchases $100K+
Latest Insider Sales
Latest Insider Sales $25K+
Latest Insider Sales $100K+
Latest Officer Sales $25K+
Latest Officer Sales $100K+
Latest CEO/CFO Sales $25K+
Latest CEO/CFO Sales $100K+
Loading alerts
50 trades of 29391 total
| File Date | Date of Earliest Transaction | Date of Latest Transaction | Ticker Symbol | Company | Insider Name | Insider Title | Buy/Sell | Transaction Count | Shares Transacted | Price | Total Transaction Value | Total Shares Owned After Transaction | Position Size Change | SEC Link |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Tax liability coverage transfers: shares are often sold to offset the tax liability from shares vesting 2026-10-09 | 2026-09-14 | 2026-09-21 | ONMD | Onemednet Corp | Golden Robert Lawrence | Chief Financial Officer | Sell | 3 | 8,500 | $6.50 | $55,290.00 | 91,291 | 8.52% | View filing |
| 10b5-1: Scheduled Form 4 Transaction 2026-10-09 | 2026-10-08 | 2026-10-08 | ULS | Ul Solutions Inc. | Scanlon Jennifer F. | President and CEO | Sell | 1 | 12,500 | $70.08 | $876,035.00 | 126,724 | 8.98% | View filing |
| 10b5-1: Scheduled Form 4 Transaction 2026-10-09 | 2026-10-08 | 2026-10-09 | MAX | Mediaalpha, Inc. | Yi Steven | CHIEF EXECUTIVE OFFICER, PRESIDENT, AND CO-FOUNDER | Sell | 2 | 26,033 | $10.11 | $263,320.02 | 2,313,707 | 1.11% | View filing |
| Unexplained: transactions without an ESPP, DRIP, 10b5-1, tax liability, or Explained M/S tag. 2026-10-09 | 2026-10-08 | 2026-10-08 | MRVL | Marvell Technology, Inc. | Scarpulla Justin | SVP, Chief Accounting Officer | Sell | 1 | 1,100 | $273.59 | $300,949.00 | 909 | 54.75% | View filing |
| 10b5-1: Scheduled Form 4 Transaction 2026-10-09 | 2026-10-07 | 2026-10-09 | BETA | Beta Technologies, Inc. | Clark Kyle | President and Chief Executive Officer | Sell | 3 | 30,000 | $20.41 | $612,234.00 | 5,115,936 | 0.58% | View filing |
| 10b5-1: Scheduled Form 4 Transaction 2026-10-09 | 2026-10-07 | 2026-10-07 | ANET | Arista Networks, Inc. | Ullal Jayshree | CEO and Chairperson | Sell | 3 | 96,992 | $217.14 | $21,060,920.47 | 4,797,347 | 1.98% | View filing |
| 10b5-1: Scheduled Form 4 Transaction 2026-10-09 | 2026-10-08 | 2026-10-08 | PCRX | Pacira Biosciences, Inc. | Riker Lauren | Senior Vice President, Finance | Sell | 1 | 6,000 | $36.32 | $217,920.00 | 62,284.24 | 8.79% | View filing |
| Tax liability coverage transfers: shares are often sold to offset the tax liability from shares vesting 2026-10-09 | 2026-10-09 | 2026-10-09 | ZYME | Zymeworks Inc. | Schayowitz Adam | EVP, Head of R&D | Sell | 1 | 13,832 | $25.85 | $357,557.20 | 23,205 | 37.35% | View filing |
| 10b5-1: Scheduled Form 4 Transaction 2026-10-09 | 2026-10-07 | 2026-10-07 | S | Sentinelone, Inc. | Parekh Sonalee Elizabeth | Chief Financial Officer | Sell | 1 | 16,304 | $25.35 | $413,291.73 | 874,610 | 1.83% | View filing |
| Tax liability coverage transfers: shares are often sold to offset the tax liability from shares vesting 2026-10-09 | 2026-10-07 | 2026-10-07 | CRNC | Cerence Inc. | Rodriquez Antonio | CFO | Sell | 1 | 76,614 | $8.00 | $612,912.00 | 500,632 | 13.27% | View filing |
| 10b5-1: Scheduled Form 4 Transaction 2026-10-09 | 2026-10-08 | 2026-10-09 | CVSA | Covista Inc. | Beard, Stephen W. | Chairman & CEO | Sell | 2 | 8,306 | $130.59 | $1,084,711.71 | 469,158 | 1.74% | View filing |
| 10b5-1: Scheduled Form 4 Transaction 2026-10-09 | 2026-10-07 | 2026-10-08 | OKTA | Okta, Inc. | Ninan Shibu | Chief Accounting Officer | Sell | 4 | 14,677 | $217.80 | $3,196,602.91 | 11,071 | 57.00% | View filing |
| Tax liability coverage transfers: shares are often sold to offset the tax liability from shares vesting 2026-10-09 | 2026-10-07 | 2026-10-07 | CRNC | Cerence Inc. | Krzanich Brian M | Chief Executive Officer | Sell | 1 | 21,703 | $8.00 | $173,624.00 | 1,700,388 | 1.26% | View filing |
| Tax liability coverage transfers: shares are often sold to offset the tax liability from shares vesting 2026-10-09 | 2026-10-07 | 2026-10-07 | CRNC | Cerence Inc. | Mentz Christian | EVP, Chief Revenue Officer | Sell | 1 | 48,923 | $8.00 | $391,384.00 | 244,551 | 16.67% | View filing |
| Tax liability coverage transfers: shares are often sold to offset the tax liability from shares vesting 2026-10-09 | 2026-10-07 | 2026-10-07 | IMVT | Immunovant, Inc. | Van Tuyl Christopher | Chief Legal Officer | Sell | 1 | 1,327 | $32.06 | $42,543.62 | 175,218 | 0.75% | View filing |
| Tax liability coverage transfers: shares are often sold to offset the tax liability from shares vesting 2026-10-09 | 2026-10-07 | 2026-10-07 | CRNC | Cerence Inc. | Salinas Jennifer | EVP Chief Admin Officer | Sell | 1 | 66,153 | $8.00 | $529,224.00 | 627,876 | 9.53% | View filing |
| Tax liability coverage transfers: shares are often sold to offset the tax liability from shares vesting 2026-10-09 | 2026-10-07 | 2026-10-07 | IMVT | Immunovant, Inc. | Stout Jay S | Chief Technology Officer | Sell | 2 | 3,809 | $32.06 | $122,116.54 | 201,532 | 1.85% | View filing |
| Tax liability coverage transfers: shares are often sold to offset the tax liability from shares vesting 2026-10-09 | 2026-10-07 | 2026-10-07 | IMVT | Immunovant, Inc. | Gloria Melanie | Chief Operating Officer | Sell | 1 | 2,241 | $32.06 | $71,846.46 | 217,060 | 1.02% | View filing |
| Tax liability coverage transfers: shares are often sold to offset the tax liability from shares vesting 2026-10-09 | 2026-10-07 | 2026-10-07 | CRNC | Cerence Inc. | Schanz Nils | EVP Product & Technology | Sell | 1 | 52,439 | $8.00 | $419,512.00 | 290,243 | 15.30% | View filing |
| 10b5-1: Scheduled Form 4 Transaction 2026-10-09 | 2026-10-08 | 2026-10-08 | ACN | Accenture Plc | Hogan Catherine Kiernan | Chief Operating Officer | Sell | 1 | 1,320 | $200.00 | $264,000.00 | 12,556 | 9.51% | View filing |
| 10b5-1: Scheduled Form 4 Transaction 2026-10-09 | 2026-10-08 | 2026-10-08 | CRCL | Circle Internet Group, Inc. | Chandhok Nikhil | Chief Product & Tech. Officer | Sell | 1 | 26,668 | $79.59 | $2,122,506.12 | 715,331 | 3.59% | View filing |
| 10b5-1: Scheduled Form 4 Transaction 2026-10-09 | 2026-10-07 | 2026-10-07 | DDOG | Datadog, Inc. | Le-Quoc Alexis | Chief Technology Officer | Sell | 9 | 53,912 | $273.60 | $14,750,067.31 | 488,033 | 9.95% | View filing |
| 10b5-1: Scheduled Form 4 Transaction 2026-10-09 | 2026-10-08 | 2026-10-09 | BNTX | Biontech Se | Sahin Ugur | Chief Executive Officer | Sell | 2 | 63,209 | $94.07 | $5,945,855.22 | 0 | 100.00% | View filing |
| 10b5-1: Scheduled Form 4 Transaction 2026-10-09 | 2026-10-07 | 2026-10-07 | SMCI | Super Micro Computer, Inc. | Liang Charles | President and CEO | Sell | 1 | 100,000 | $45.02 | $4,502,000.00 | 337,506 | 22.86% | View filing |
| Unexplained: transactions without an ESPP, DRIP, 10b5-1, tax liability, or Explained M/S tag. 2026-10-09 | 2026-10-08 | 2026-10-08 | HNST | Honest Company, Inc. | Sternweis Thomas | SVP, Enterprise Dev. & Strat | Sell | 1 | 25,000 | $4.90 | $122,500.00 | 404,394 | 5.82% | View filing |
| 10b5-1: Scheduled Form 4 Transaction 2026-10-09 | 2026-10-08 | 2026-10-08 | DIS | Walt Disney Co | Woodford Brent | EVP, Control, Fin Plan & Tax | Sell | 1 | 3,618 | $105.31 | $381,011.58 | 62,995 | 5.43% | View filing |
| 10b5-1: Scheduled Form 4 Transaction 2026-10-09 | 2026-10-07 | 2026-10-08 | VINP | Vinci Compass Investments Ltd. | Lovisotto Fernando | Head of Global IP&S | Sell | 2 | 6,948 | $10.86 | $75,448.92 | 962,310 | 0.72% | View filing |
| 10b5-1: Scheduled Form 4 Transaction 2026-10-09 | 2026-10-08 | 2026-10-08 | VRSN | Verisign Inc/Ca | Indelicarto Thomas C | EVP, Gen Counsel & Secretary | Sell | 1 | 500 | $293.14 | $146,570.00 | 31,894.53 | 1.54% | View filing |
| 10b5-1: Scheduled Form 4 Transaction 2026-10-09 | 2026-10-08 | 2026-10-08 | UTHR | United Therapeutics Corp | Rothblatt Martine A | Chairperson & CEO | Sell | 16 | 9,500 | $534.31 | $5,075,918.83 | 324,443 | 2.84% | View filing |
| 10b5-1: Scheduled Form 4 Transaction 2026-10-09 | 2026-10-07 | 2026-10-07 | SMTC | Semtech Corp | Green Jason Elliot | EVP and CCO | Sell | 1 | 2,766 | $190.35 | $526,508.10 | 7,367 | 27.30% | View filing |
| Unexplained: transactions without an ESPP, DRIP, 10b5-1, tax liability, or Explained M/S tag. 2026-10-09 | 2026-06-15 | 2026-06-15 | EVRG | Evergy, Inc. | Caisley Charles A. | EVP & CHIEF CUST OFFCR | Sell | 1 | 1,198 | $83.46 | $99,985.08 | 36,591 | 3.17% | View filing |
| 10b5-1: Scheduled Form 4 Transaction 2026-10-09 | 2026-10-08 | 2026-10-08 | NP | Neptune Insurance Holdings Inc. | Duffy Matthew Paul | President & Chief Risk Officer | Sell | 2 | 84,441 | $28.10 | $2,372,429.95 | 1,879,798 | 4.30% | View filing |
| 10b5-1: Scheduled Form 4 Transaction 2026-10-09 | 2026-10-07 | 2026-10-07 | DUOL | Duolingo, Inc. | Von Ahn Luis | President & CEO, Co-Founder | Sell | 4 | 110,046 | $151.70 | $16,693,999.87 | 0 | 100.00% | View filing |
| Unexplained: transactions without an ESPP, DRIP, 10b5-1, tax liability, or Explained M/S tag. 2026-10-09 | 2026-10-07 | 2026-10-07 | LE | Lands' End, Inc. | Maas Kym | President, Product & CCO | Sell | 1 | 10,000 | $10.59 | $105,900.00 | 25,706 | 28.01% | View filing |
| Unexplained: transactions without an ESPP, DRIP, 10b5-1, tax liability, or Explained M/S tag. 2026-10-09 | 2026-10-07 | 2026-10-07 | IDT | Idt Corp | Mason Joyce J | EVP and Corporate Secretary | Sell | 1 | 1,150 | $80.50 | $92,570.29 | 11,372 | 9.18% | View filing |
| Tax liability coverage transfers: shares are often sold to offset the tax liability from shares vesting 2026-10-09 | 2026-10-08 | 2026-10-08 | URGN | Urogen Pharma Ltd. | Degnan Chris | Chief Financial Officer | Sell | 1 | 2,202 | $36.69 | $80,791.38 | 4,561 | 32.56% | View filing |
| 10b5-1: Scheduled Form 4 Transaction 2026-10-09 | 2026-10-07 | 2026-10-08 | SE | Sea Ltd | Wang Yanjun | CCO and GC | Sell | 4 | 2,000 | $94.06 | $188,124.78 | 83,780 | 2.33% | View filing |
| 10b5-1: Scheduled Form 4 Transaction 2026-10-08 | 2026-10-06 | 2026-10-07 | CRWD | Crowdstrike Holdings, Inc. | Kurtz George | PRESIDENT AND CEO | Sell | 21 | 20,000 | $274.72 | $5,494,349.02 | 7,511,504 | 0.27% | View filing |
| 10b5-1: Scheduled Form 4 Transaction 2026-10-08 | 2026-10-06 | 2026-10-08 | HALO | Halozyme Therapeutics, Inc. | Torley Helen | PRESIDENT AND CEO | Sell | 12 | 60,000 | $110.18 | $6,610,500.79 | 767,780 | 7.25% | View filing |
| 10b5-1: Scheduled Form 4 Transaction 2026-10-08 | 2026-10-07 | 2026-10-07 | VST | Vistra Corp. | Moldovan Kristopher E. | EVP and CFO | Sell | 1 | 20,000 | $165.00 | $3,300,000.00 | 179,044 | 10.05% | View filing |
| 10b5-1: Scheduled Form 4 Transaction 2026-10-08 | 2026-10-06 | 2026-10-06 | ANET | Arista Networks, Inc. | Ullal Jayshree | CEO and Chairperson | Sell | 9 | 460,374 | $212.09 | $97,642,614.07 | 4,811,207 | 8.73% | View filing |
| 10b5-1: Scheduled Form 4 Transaction 2026-10-08 | 2026-10-06 | 2026-10-06 | IDYA | Ideaya Biosciences, Inc. | Hata Yujiro S | President and CEO | Sell | 2 | 26,338 | $37.41 | $985,396.73 | 690,695 | 3.67% | View filing |
| 10b5-1: Scheduled Form 4 Transaction 2026-10-08 | 2026-10-07 | 2026-10-08 | ADPT | Adaptive Biotechnologies Corp | Rubinstein Julie | President and COO | Sell | 2 | 23,762 | $26.03 | $618,524.86 | 377,802 | 5.92% | View filing |
| 10b5-1: Scheduled Form 4 Transaction 2026-10-08 | 2026-10-06 | 2026-10-06 | ADPT | Adaptive Biotechnologies Corp | Rubinstein Julie | President and COO | Sell | 4 | 11,881 | $27.75 | $329,698.34 | 377,802 | 3.05% | View filing |
| 10b5-1: Scheduled Form 4 Transaction 2026-10-08 | 2026-10-06 | 2026-10-06 | ADPT | Adaptive Biotechnologies Corp | Bobulsky Susan | Chief Commercial Officer, MRD | Sell | 1 | 6,444 | $30.00 | $193,320.00 | 389,350 | 1.63% | View filing |
| 10b5-1: Scheduled Form 4 Transaction 2026-10-08 | 2026-10-06 | 2026-10-06 | AAPL | Apple Inc. | Newstead Jennifer | SVP, GC and Government Affairs | Sell | 1 | 2,399 | $332.01 | $796,491.99 | 39,593 | 5.71% | View filing |
| Unexplained: transactions without an ESPP, DRIP, 10b5-1, tax liability, or Explained M/S tag. 2026-10-08 | 2026-10-06 | 2026-10-06 | ARQQ | Arqit Quantum Inc. | Leaver Andrew | Chief Executive Officer | Sell | 1 | 2,398 | $24.19 | $58,011.22 | 51,330 | 4.46% | View filing |
| 10b5-1: Scheduled Form 4 Transaction 2026-10-08 | 2026-10-08 | 2026-10-08 | GDYN | Grid Dynamics Holdings, Inc. | Gryzlov Yury | CHIEF OPERATING OFFICER | Sell | 1 | 4,849 | $8.00 | $38,792.00 | 495,290 | 0.97% | View filing |
| 10b5-1: Scheduled Form 4 Transaction 2026-10-08 | 2026-10-06 | 2026-10-06 | BFLY | Butterfly Network, Inc. | Devivo Joseph | President & CEO | Sell | 1 | 35,790 | $10.02 | $358,615.80 | 7,311,930 | 0.49% | View filing |
| 10b5-1: Scheduled Form 4 Transaction 2026-10-08 | 2026-10-06 | 2026-10-06 | CRSP | Crispr Therapeutics Ag | Kasinger James R. | General Counsel and Secretary | Sell | 1 | 1,990 | $60.04 | $119,481.19 | 94,784 | 2.06% | View filing |
Loading alerts